Skip to main content
TipRanks
Go Ultimate75% OFF

Brooks Laboratories Limited (BROOKS) Stock Statistics & Valuation Metrics

2 Followers

Total Valuation

Brooks Laboratories Limited has a market cap or net worth of INR 2.06B. The enterprise value is INR 1.05B.

Market Cap
INR 2.06B
Enterprise Value
INR 1.05B

Share Statistics

Brooks Laboratories Limited has 29,457,249 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
29,457,249
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

Brooks Laboratories Limited’s return on equity (ROE) is 0.20 and return on invested capital (ROIC) is 4.12%.

Return on Equity (ROE)
0.20
Return on Assets (ROA)
0.17
Return on Invested Capital (ROIC)
4.12%
Return on Capital Employed (ROCE)
0.04
Revenue Per Employee
2.47M
Profits Per Employee
708.46K
Employee Count
347
Asset Turnover
0.58
Inventory Turnover
6.15

Valuation Ratios

The current PE Ratio of Brooks Laboratories Limited is 2.83. Brooks Laboratories Limited’s PEG ratio is 0.01.

PE Ratio
2.83
PS Ratio
2.61
PB Ratio
1.09
Price to FCF
0.00
Price to Operating Cash Flow
0.00
PEG Ratio
0.01

Income Statement

In the last 12 months, Brooks Laboratories Limited had revenue of 857.38M and earned 245.84M in profits. Earnings per share was 8.35.

Revenue
857.38M
Gross Profit
179.65M
Operating Income
54.70M
Pretax Income
245.84M
Net Income
245.84M
EBITDA
270.09M
Earnings Per Share (EPS)
8.35

Cash Flow

In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.

Operating Cash Flow
0
Free Cash Flow
0
Free Cash Flow per Share
0.00

Dividends & Yields

Brooks Laboratories Limited pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
0.00%
Earnings Yield
35.38%

Stock Price Statistics

Beta
1.56
52-Week Price Change
-34.67%
50-Day Moving Average
62.78
200-Day Moving Average
63.25
Relative Strength Index (RSI)
59.91
Average Volume (3m)
12.86K

Important Dates

Brooks Laboratories Limited upcoming earnings date is Feb 17, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 07, 2026
Next Earnings Date
Feb 17, 2027
Ex-Dividend Date
―

Financial Position

Brooks Laboratories Limited as a current ratio of 1.72, with Debt / Equity ratio of 6.94%

Current Ratio
1.72
Quick Ratio
1.21
Debt to Market Cap
0.07
Net Debt to EBITDA
0.04
Interest Coverage Ratio
6.55

Taxes

In the past 12 months, Brooks Laboratories Limited has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

Brooks Laboratories Limited EV to EBITDA ratio is 29.26, with an EV/FCF ratio of 0.00.

EV to Sales
1.88
EV to EBITDA
29.26
EV to Free Cash Flow
0.00
EV to Operating Cash Flow
0.00

Balance Sheet

Brooks Laboratories Limited has INR 654.25M in cash and marketable securities with INR 70.97M in debt, giving a net cash position of INR 583.28M billion.

Cash & Marketable Securities
INR 654.25M
Total Debt
INR 70.97M
Net Cash
INR 583.28M
Net Cash Per Share
INR 19.80
Tangible Book Value Per Share
INR 63.98

Margins

Gross margin is 20.34%, with operating margin of 2.44%, and net profit margin of 92.23%.

Gross Margin
20.34%
Operating Margin
2.44%
Pretax Margin
98.96%
Net Profit Margin
92.23%
EBITDA Margin
6.41%
EBIT Margin
4.30%

Analyst Forecast

The average price target for Brooks Laboratories Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
-14.88%
EPS Growth Forecast
431.30%

Scores

Smart Score
―
AI Score
63